Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug
Por um escritor misterioso
Descrição
JCM, Free Full-Text
Assessment and Monitoring, Ankylosing Spondylitis
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients, Arthritis Research & Therapy
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis – topic of research paper in Clinical medicine.
Cureus, Tumor Necrosis Factor-Alpha (+489 G/A) Polymorphism Can Predict the Response to Adalimumab in Chinese Han Patients With Ankylosing Spondylitis
EULAR Abstract Archive
Interrupted course of antitumor necrosis factor alpha therapy versus combined nonsteroidal anti-inflammatory drug therapy and physiotherapy in patients with ankylosing spondylitis: A comparative study Abdelrahman SK, M. Mostafa TF - J Med
SIMPONI ARIA® Ankylosing Spondylitis: Partial Remission
Cureus, Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis
Ankylosing spondylitis remission: Definition and more
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study, BMC Musculoskeletal Disorders
de
por adulto (o preço varia de acordo com o tamanho do grupo)
